Clinical management of patients with gastric MALT lymphoma: a gastroenterologist's point of view
T Matysiak-Budnik, K Priadko, C Bossard, N Chapelle… - Cancers, 2023 - mdpi.com
Simple Summary Gastric mucosa-associated lymphoid tissue (MALT) lymphomas represent
rare gastric neoplasia usually localized and of indolent course, characterized by an …
rare gastric neoplasia usually localized and of indolent course, characterized by an …
[HTML][HTML] Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma
S Teckie, S Qi, M Chelius, S Lovie, M Hsu, A Noy… - Annals of …, 2017 - Elsevier
Background Localized early-stage extra-nodal marginal zone lymphoma (MZL) presents
with heterogeneous organ involvement and is treated with various modalities, including …
with heterogeneous organ involvement and is treated with various modalities, including …
Prognostic role of baseline 18F‐FDG PET/CT parameters in MALT lymphoma
Mucosa‐associated lymphoid tissue (MALT) lymphoma is an indolent lymphoma with good
prognosis and variable fluorine‐18 fluorodeoxyglucose (18F‐FDG) avidity. Many possible …
prognosis and variable fluorine‐18 fluorodeoxyglucose (18F‐FDG) avidity. Many possible …
Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin
S Stollberg, D Kämmerer, E Neubauer, S Schulz… - Journal of cancer …, 2016 - Springer
Purpose Whereas the different somatostatin receptor (SSTR) subtypes and the chemokine
receptor CXCR4 are known to be expressed in a wide variety of human malignancies …
receptor CXCR4 are known to be expressed in a wide variety of human malignancies …
Validation of the marginal zone lymphoma international prognostic index
Abstract The Marginal Zone Lymphoma International Prognostic Index (MALT-IPI) was
recently developed for use in patients with mucosa-associated lymphoid tissue (MALT) …
recently developed for use in patients with mucosa-associated lymphoid tissue (MALT) …
Matching-adjusted indirect comparisons of zanubrutinib (MAGNOLIA, BGB-3111-AU-003) versus ibrutinib (PCYC-1121) and rituximab (CHRONOS-3) in relapsed …
In the absence of head-to-head randomized trials, unanchored matching-adjusted indirect
comparisons were conducted to estimate the relative efficacy of zanubrutinib versus ibrutinib …
comparisons were conducted to estimate the relative efficacy of zanubrutinib versus ibrutinib …
MALT lymphoma of the base of the tongue: a rare case entity
Lymphoma is a malignant tumour arising from lymphoid tissue, with the majority of cases
being in the lymph nodes, however, in 1/4th of cases, these tumours are found in …
being in the lymph nodes, however, in 1/4th of cases, these tumours are found in …
MALT lymphoma at the base of tongue of a 29-year-old woman treated with radiation therapy alone
JH Song, DI Sun, YS Hong, GS Park… - Journal of Cancer …, 2014 - journals.lww.com
Mucosa-associated lymphoid tissue (MALT) lymphoma is frequently reported in the
gastrointestinal tract (GIT), but the incidence is low in the upper aerodigestive tract. In …
gastrointestinal tract (GIT), but the incidence is low in the upper aerodigestive tract. In …
Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa‐associated lymphoid tissue (MALT) lymphoma
X Xu, Z Wang, Y Yu, Y Wang, L Zhang… - Journal of …, 2014 - Wiley Online Library
Abstract Background and Aim This study was undertaken to evaluate the clinical
characteristics, prognostic factors, and long‐term outcomes of patients with mucosa …
characteristics, prognostic factors, and long‐term outcomes of patients with mucosa …
[HTML][HTML] The characteristic computed tomography findings of pulmonary B-cell non-Hodgkin's lymphoma and their role in predicting patient survival
Y Wang, ZC Pan, L Zhu, YY Ma, MC Zhang… - … Imaging in Medicine …, 2021 - ncbi.nlm.nih.gov
Background To assess the value of characteristic computed tomography (CT) findings in
predicting the survival of patients with pulmonary B-cell non-Hodgkin's lymphoma (NHL) …
predicting the survival of patients with pulmonary B-cell non-Hodgkin's lymphoma (NHL) …